Abstract
Background
In the United States, lung cancer screening (LCS) via low-dose computed tomography is recommended for adults at high risk, but LCS uptake is poor, particularly among patients with lower socioeconomic status (SES). We evaluated neighborhood disadvantage, a measure of SES, as a predictor of LCS completion rates among primary care patients seen in the Washington, D.C. and Maryland area to understand how neighborhood disadvantage may impact LCS completion.
Methods
Utilizing electronic health record data, we calculated LCS completion rates in the past 12 months among patients who received an LCS order (N = 829) to a hybrid LCS program between September 2022 and August 2023 at 51 primary care clinics. To measure neighborhood disadvantage, we used the census block level Area Deprivation Index (ADI), a composite index of demographic and socioeconomic variables. The state-specific ADI decile is ranked on a scale of 1 to 10, with a higher score reflecting greater neighborhood disadvantage. A logistic regression model with generalized estimating equations (GEE) assessed the association of ADI with LCS completion, controlling for race, smoking status, minutes required to travel to the nearest LCS screening location, and clinic type.
Results
Most potentially eligible patients who received a LCS order (766, 92.4%) had a standardized address that could be linked to ADI data. The mean age was 66 (standard deviation = 7) years, 35% were Black or African-American, and 65% were currently smoking. Among patients ordered an LCS, the overall completion rate was 24%. The ADI was inversely associated with LCS completion: a one decile increase in ADI corresponded to significantly lower odds of completing LCS (odds ratio = 0.91, 95% confidence interval: 0.86–0.97).
Conclusions
In a large, socioeconomically diverse health system, higher neighborhood disadvantage was associated with lower completion among patients ordered an LCS. While a LCS order is necessary to access LCS, strategies that consider neighborhood context are needed to increase successful completion of LCS among lower SES groups. Primary care practices may be an effective setting for these strategies due to their focus on cancer screenings and role as often being the first point of contact for LCS.
This study was approved by the Georgetown-MedStar Institutional Review Board (STUDY00009269).
Supplementary Information
The online version contains supplementary material available at 10.1186/s12875-026-03395-2.
Keywords: Lung cancer screening, Primary care, Area deprivation index, Neighborhood disadvantage
Background
Lung cancer is the leading cause of cancer-related mortality in the United States (U.S.), with more than 125,000 deaths expected in 2026 [1]. Previous lung cancer screening (LCS) trials, including the National Lung Screening Trial and Nederlands–Leuvens Longkanker Screenings Onderzoek (NELSON) trial, showed that LCS via low-dose computed tomography reduced lung cancer mortality by 20–24% [2, 3]. Due to this, the U.S. Preventive Services Task Force currently recommends annual LCS for asymptomatic high-risk individuals, however, utilization is poor [4]. The causes of low utilization of LCS are multifactorial including individual-level factors like low socioeconomic status (SES) [5–9].
Primary care serves an essential role in the uptake of LCS because primary care providers are often the first point of contact in the health care system for many patients [10, 11] and are responsible for identifying screening-eligible patients, providing information regarding screening, facilitating shared decision making, placing the order, and following up on results [12, 13]. While an LCS order is necessary, it may not be sufficient to increase LCS rates. There is evidence that even after receiving an order some populations, including lower income individuals, may encounter more barriers to completing LCS, which results in missed opportunities to diagnose lung cancer at earlier stages [14–16].
Previous studies on LCS uptake have focused on the role of health system-, provider-, and patient-level characteristics [16–19], however, additional efforts are needed to understand how neighborhood context may influence individual LCS behavior and to support primary care practices in addressing barriers this context may pose. For instance, prior literature for other cancer screenings highlight how neighborhood disadvantage may be associated with screening behavior [20–23]. Although area-level differences, such as rurality, have been examined to evaluate access to LCS [24–27], few studies have focused on how neighborhood disadvantage may impact LCS [9, 28]. To improve LCS utilization, an increased understanding of neighborhood context is needed in order to develop targeted interventions that will support LCS completion and guide primary care clinics in implementing these strategies.
The Area Deprivation Index (ADI) is a scientifically validated measure that ranks neighborhoods by disadvantage at the state and national level [29]. Numerous studies using the ADI have demonstrated an association with cancer screening outcomes [30–33]. To our knowledge, the present study is the first to assess the association of the ADI with LCS completion among primary care patients. Thus, our study aimed to examine neighborhood disadvantage as a predictor of LCS completion rates among primary care patients utilizing electronic health record (EHR) data from an integrated delivery network health system and the largest healthcare provider in Maryland and the District of Columbia (D.C.) metropolitan region [34].
Methods
Setting
Currently, this integrated delivery network health system consists of 10 hospitals, 60 primary care clinics, and multiple other sites of care across D.C., Maryland, and Virginia. Primary care includes over 320 providers who are physicians, physician assistants, and nurse practitioners. This study included 51 primary care clinics in D.C. and Maryland. At the time of data collection, this integrated delivery network health system had 56 primary care clinics. Five pediatrics clinics were excluded from the analysis. This mid-Atlantic health system uses the Oracle Cerner EHR and it delivers LCS through a hybrid approach, with two hospital-based centralized programs and decentralized sites throughout the rest of the system.
Study population
We conducted a retrospective data analysis utilizing EHR data from September 1, 2022 to August 31, 2024. The inclusion criteria were: individuals who had a primary care clinic visit and who were between the ages of 50–80 years at the time of the appointment, had a smoking history (i.e., currently smoking or formerly smoked), and did not have a previous lung cancer diagnosis. Due to the high missingness of pack years (85% missing), years since quit, duration, and other variables used to determine LCS eligibility, further exclusion based on available smoking history data was not feasible and this this resulted in a sample of patients who were potentially eligible for LCS. We excluded patients residing in Virginia and other states as the health system is primarily concentrated in the D.C. and Maryland regions. This study was approved by the Georgetown-MedStar Institutional Review Board (STUDY00009269) and the need to consent was waived.
Data elements
Demographic and clinical characteristics
Race, sex, age, residential address, and insurance type were extracted from the EHR and used to characterize the sample. The primary care clinic location was included in our dataset, allowing us to determine the type of primary care clinic (community-based vs. hospital-based).
Smoking history
Where available, we included packs per day, duration (age started smoking; age stopped smoking (if formerly smoked), and pack years (total packs per day smoked multiplied by total years smoked) from the social history form in the EHR.
Lung cancer screening eligibility
Due to the high missingness of smoking-related data within the EHR [35, 36], we were unable to determine how many patients were eligible for lung cancer screening according to the U.S. Preventive Services Task Force eligibility criteria (i.e., 50–80 years old, 20 pack years or more, currently smoking or have quit within 15 years). Of the patients with available data, we categorized packs per day, duration, and pack years to determine the distribution. There was no missingness for smoking status as having a previous smoking history was a requirement to be included in the dataset. For patients who were ordered a LCS, we abstracted smoking status (yes, currently smoking vs. no, not currently smoking) and if the patient discussed smoking cessation with the provider (yes vs. no) from the LCS order form. In this integrated delivery network health system, an LCS recommendation fires annually on January 1st for individuals who are 50–80 years of age with an ever-smoking history to prompt the provider to assess smoking history and LCS eligibility.
Area deprivation index
The ADI is a scientifically validated measure of neighborhood disadvantage that was last updated in 2023 and calculates a score based on U.S. Census American Community Survey 5-Year Data related to income, housing, education, and occupation and ranks neighborhoods using state-based and national percentiles [29]. The ADI has been used in prior studies that have abstracted data from the EHR [37]. We used the state-specific ADI deciles as it ranks a neighborhood’s socioeconomic disadvantage against other census block groups within a specific state. The ADI was included as a continuous variable in the Generalized Estimating Equations (GEEs). Residential addresses of the patients were abstracted from the EHR. We used the Census Geocoder and the “Public_AR_Current” benchmark to match patients’ addresses with geographic identifiers.
LCS order and completion (Primary Outcome)
LCS order was defined as having the scan ordered (yes vs. no) in the first 12 months of the data period (September 1, 2022 to August 31, 2023). LCS completion rate was defined as having the scan completed (yes vs. no) within the following 12 months among patients who received a LCS order. The 12-month timeframe was chosen because LCS orders do not expire until 12 months after the order is placed in the health system. We generated a screening rate for each decile of ADI by dividing the number of orders placed in each decile by the number of completions. This was then converted to a percent.
Distance to screening location
We identified locations of LCS radiology sites in D.C. and Maryland using the LCS locator tool provided by the American College of Radiology (ACR) [38, 39]. We calculated Euclidean distance and road network distance using ArcGIS Pro (Version 3.4) [40]. We also calculated the number of minutes traveled when calculating road network distance as a complementary measure of distance.
Statistical analysis
To assess the association between neighborhood deprivation and LCS completion with consideration of covariates, we first conducted bivariate analyses using chi-square and ANOVA tests. A t-test was also performed to compare those who complete the LCS with those who did not with regard to the means of continuous variables that had a significance association with completion. In multivariable analyses, we accounted for clustering at clinic level by using a GEE approach. We used a logistic regression model with GEE to examine the association of LCS completion with ADI as the primary predictor. Based on the results of the bivariate analyses, variables that were found to be significantly associated with LCS completion (p < 0.05) in the bivariate analysis were included in the logistic regression model with GEE. An exchangeable working correlation structure was employed and Wald chi-square tests were used to determine the significance of results. To evaluate the presence of a linear effect of ADI (on the log odds scale) we first treated it as a categorical variable (with 10 levels) and the log odds were plotted; the results supported linearity. As such, ADI was included as a continuous variable in the final model.
Results are presented as estimated odds ratios (ORs) with corresponding 95% confidence intervals (CIs). IBM SPSS (Version 29) [41] was used for the analysis; ArcGIS was used for generating maps to visually display data. A significance level of 0.05 was used to determine statistical significance.
Results
Population characteristics
From September 1, 2022 and August 31, 2023, N = 28,738 patients between the age of 50–80, with an ever-smoking history, and no previous lung cancer diagnosis were seen at least once for a primary care appointment in this integrated delivery health network. The mean age was 63 (standard deviation (SD) = 8) years, 32% were Black or African-American, and, using the most recent smoking status from the EHR, 10% were currently smoking. Of the 28,738, only 829 had an LCS order. We were not able to use data regarding total pack-years or years quit to confirm smoking history eligibility among patients with an LCS order. It is possible that some patients with an LCS order were ineligible or that confirmation of a patient’s LCS eligibility was documented elsewhere in the medical record such as in the clinical notes. Of those patients who had received an order, 766 had an address in the EHR that could be linked to the ADI measure and lived in D.C. or Maryland. The mean age was 65 (SD = 7) years and 35% were Black or African-American.
Of the 766 patients, 41% had smoking duration data available, 2.5% had a stop age, 71% had packs per day, and 20% had total pack years documented in the EHR based on their last recorded smoking history (Table 1). For the last recorded smoking status from the EHR, 54% were listed as currently smoking, 41% as formerly smoked, and 5% as having denied smoking. However, the 5% who denied smoking at their last visit previously had current or former listed as their smoking status due to our requirement of having an “ever smoked” history. All patients had a smoking status (65% currently smoking, 35% formerly smoked) listed in their LCS order form as it is a required field. Of those who were listed as currently smoking on their order form, n = 463 (93%) had discussed smoking cessation with their provider. Among patients ordered a LCS, the overall completion rate was 24%.
Table 1.
Data availability for last recorded smoking history variables from EHR among 766 participants
| Smoking-related Variables | LCS Completion Status | ||||
|---|---|---|---|---|---|
| Incomplete (n = 585, 76%) | Complete (n = 181, 24%) | Total (N = 766) | |||
| N | % | N | % | N | |
| LCS Order Form Status - Currently Smoking?* | |||||
| Yes | 400 | 80% | 100 | 20% | 500 |
| No | 185 | 70% | 81 | 30% | 266 |
| Smoking status from EHR | |||||
| Current | 333 | 80% | 84 | 20% | 417 |
| Denies | 30 | 86% | 5 | 14% | 35 |
| Former | 222 | 71% | 92 | 29% | 314 |
| Availability of years smoked | |||||
| Data missing | 360 | 80% | 89 | 20% | 449 |
| Data available | 225 | 71% | 92 | 29% | 317 |
| Years smoked among documented | |||||
| Less than 10 years | 7 | 88% | 1 | 13% | 8 |
| 10–19 years | 11 | 79% | 3 | 21% | 14 |
| 20–29 years | 25 | 56% | 20 | 44% | 45 |
| 30 or more years | 182 | 73% | 68 | 27% | 250 |
| Availability of stop age | |||||
| Data missing | 570 | 76% | 177 | 24% | 747 |
| Data available | 15 | 79% | 4 | 21% | 19 |
| Stop age among documented | |||||
| < 50 years old | 2 | 67% | 1 | 33% | 3 |
| ≥ 50 years old | 13 | 81% | 3 | 19% | 16 |
| Availability of packs per day | |||||
| Data missing | 169 | 76% | 54 | 24% | 223 |
| Data available | 416 | 77% | 127 | 23% | 543 |
| Packs per day among documented | |||||
| < 1 PPD | 167 | 76% | 52 | 24% | 219 |
| 1 < 2 PPD | 196 | 77% | 58 | 23% | 254 |
| ≥ 2 PPD | 53 | 76% | 17 | 24% | 70 |
| Availability of pack years | |||||
| Data missing | 481 | 79% | 128 | 21% | 609 |
| Data available | 104 | 66% | 53 | 34% | 157 |
| Pack years among documented | |||||
| 20–30 pack years | 3 | 60% | 2 | 40% | 5 |
| > 30 pack years | 101 | 66% | 51 | 34% | 152 |
*p < 0.05
Black patients were more likely to complete LCS than White patients (30% vs. 19%, p = 0.002), as were patients who formerly smoked compared to patients who currently smoke (30% vs. 20%, p = 0.001) (Table 2). Patients seen at hospital-based clinics were more likely to complete their LCS than patients seen at community-based clinics (28% vs. 21%, p = 0.031). Furthermore, a higher ADI decile (p = 0.008), more minutes to travel to the nearest LCS site (p=0.024), and a greater Euclidean distance in miles (p < 0.001) were associated with not completing LCS. Supplemental Material 1 includes the distribution of patient characteristics and continuous area-level variables by category of ADI to provide additional context for the covariates.
Table 2.
Distribution of participant characteristics, overall and by LCS completion status among 766 patients
| Characteristics | Completion Status | ||||
|---|---|---|---|---|---|
| Incomplete (n = 585, 76%) | Complete (n = 181, 24%) | ||||
| N | % | N | % | Total (N = 766) | |
| Age, M (SD) | 66 (6) | 65 (7) | 65 (7) | ||
| Sex | |||||
| Female | 293 | 76% | 95 | 24% | 388 |
| Male | 292 | 77% | 86 | 23% | 378 |
| Race** | |||||
| Black | 188 | 70% | 80 | 30% | 268 |
| White | 362 | 81% | 85 | 19% | 447 |
| Other | 35 | 69% | 16 | 31% | 51 |
| Insurance | |||||
| Government/Medicaid/Medicare/MCO | 223 | 76% | 70 | 24% | 293 |
| Commercial/Private | 336 | 78% | 97 | 22% | 433 |
| Self pay/other | 12 | 80% | 3 | 20% | 15 |
| Missing | 14 | 11 | 25 | ||
| Clinic Type | |||||
| Hospital-based/Resident Clinic | 176 | 72% | 70 | 28% | 246 |
| Community-based | 409 | 79% | 111 | 21% | 520 |
| State of Residence | |||||
| Maryland (MD) | 518 | 83% | 108 | 17% | 626 |
| District of Columbia (DC) | 67 | 48% | 73 | 52% | 140 |
| Area-level Variables | |||||
| ADI Score (State-specific), M (SD) [1–10]*** | 6 (3) | 5 (3) | 6 (3) | ||
| Low (1–4) | 186 | 71% | 76 | 29% | 262 |
| Medium (5–7) | 177 | 78% | 51 | 22% | 228 |
| High (8–10) | 222 | 80% | 54 | 20% | 276 |
| Euclidean Distance (Miles), M (SD)** | 6 (3) | 5 (4) | 6 (4) | ||
| Road Network Distance (Miles), M (SD) | 7 (4) | 7 (6) | 7 (4) | ||
| Travel Minutes to Nearest LCS Site, M (SD)*** | 21 (9) | 18 (9) | 20 (9) | ||
*p < 0.1, **p < 0.5, ***p < 0.001
ADI and LCS completion
ADI was inversely associated with LCS completion: a one unit increase in ADI corresponded to significantly lower odds of completing LCS (OR = 0.91; 95% CI: 0.86–0.97; p = 0.004) (Table 3). Black patients (vs. white patients) had higher odds of completing their order (OR = 1.94; 95% CI: 1.33–2.83; p = 0.001). Patients who were not currently smoking (vs. currently smoking) had higher odds of completing their order (OR = 1.85; 95% CI: 1.30–2.64; p = 0.001). Finally, compared to patients with a shorter travel time in minutes to a LCS site, patients with a longer travel time to a LCS site had significantly lower odds of completing LCS (OR = 0.97; 95% CI: 0.95–0.99; p = 0.013).
Table 3.
Results for the adjusted logistic regression model with GEE
| OR | 95% CI | p-value | |
|---|---|---|---|
| Area-level variables | |||
| ADI State Decile | 0.91 | 0.85–0.97 | 0.004 |
| Travel Minutes to Nearest LCS Site | 0.97 | 0.95–0.99 | 0.013 |
| Smoking Status from LCS order (reference group: Yes, currently smoking) | |||
| No (not currently smoking) | 1.85 | 1.29–2.64 | 0.001 |
| Race (reference group: White) | |||
| Black | 1.94 | 1.33–2.83 | 0.001 |
| Other | 1.54 | 0.78–3.02 | 0.210 |
| Clinic location type (reference group: Community-based) | |||
| Hospital-based | 1.46 | 0.99–2.14 | 0.052 |
LCS completion by state ADI
A Pearson’s correlation revealed that LCS was inversely associated with ADI (r=-0.695, p = 0.026), as the percentage of scans completed was higher in Census blocks with lower neighborhood disadvantage compared to areas with higher neighborhood disadvantage (Fig. 1).
Fig. 1.
LCS completion percentages among patients with an order by ADI decile
As shown in Fig. 2, ADI was not evenly distributed across D.C., with higher ADI (i.e., greater neighborhood disadvantage) observed in neighborhoods located in the southern part of the city.
Fig. 2.
Distribution of state-specific ADI in DC by Census block group
As shown in Fig. 3, while 82% of the sample resided in Maryland, 90% of the block groups had zero patients or were not given an ADI score.
Fig. 3.
Distribution of state-specific ADI in MD by Census block group
Discussion
The aim of this retrospective data analysis was to examine if neighborhood disadvantage was associated with LCS completion among primary care patients with an order, in addition to other factors (Table 2). We found that, of those with an order, only 24% of patients completed LCS which is consistent with national LCS rates of approximately one in five eligible individuals undergoing LCS [42]. Our analysis found that the percentage of scans completed by Census block were correlated with neighborhood disadvantage (Fig. 1), and that patients living in higher deprivation areas had lower odds of completing the LCS order (Table 3). This finding is consistent with prior research [8, 9] and highlights how patients living in neighborhoods with high disadvantage may encounter more barriers to completing LCS. However, unlike our study, the patients referred to LCS in the Kim et al. and Neslund-Dudas et al. articles were evaluated before the United States Preventive Services Task Force updated their guidelines in 2021 [43]. Both studies also utilized the Yost index, a different validated neighborhood-level measure that encompasses seven neighborhood-level domains such as household income, occupation, and education [44, 45]. Additionally, Kim et al. specifically focused on adherence to annual LCS.
Our finding of patients who lived in higher deprivation areas having lower odds of completing their LCS order may also be related to our finding of patients who had a longer travel time to their nearest LCS site having significantly lower odds of completing their LCS (Table 3). Prior research supports how access to LCS sites via geographic proximity impacts lung cancer outcomes [26, 46, 47]. As such, referring patients to the nearest LCS site that accepts their insurance, rather than providing a general order to any LCS site, may help increase LCS completion. Potential interventions to increase LCS completion among patients who live in a highly disadvantaged area could include EHR modifications that would allow providers to easily find a LCS site closest to the address listed in the patient’s chart or order to a centralized LCS program that is led by trained staff who can support scheduling and offer closer tracking of LCS completions.
Patients who formerly smoked had higher odds of completing their LCS order in our study (Table 3), which underscores the importance of providing support to patients who are currently smoking to complete their LCS order. It may be especially impactful for primary care providers to address fear or reticence and stigma to complete the scan for patients who are continuing to smoke when making the order. While many interventions aim to help currently smoking LCS patients quit smoking [48], these interventions could also serve to help patients complete their LCS order. Understanding how to increase LCS uptake and completion is an active area of research. Recent meta-analyses [49–51], reviewed a variety of interventions aimed at increasing LCS orders and completion. The meta-analyses showed that patient navigation may be an effective strategy to improve LCS uptake among high-risk individuals [49] by addressing individual- and area-level barriers such as transportation [50, 52].
Additionally, in our sample, Black patients were more likely to complete their LCS order than White patients (Table 3). While this differs from findings in some studies [53, 54], it is consistent with others [55], which further underscores the importance of looking at variables beyond race to understand LCS utilization by subpopulations. This study suggests both individual-level factors and neighborhood context impact LCS uptake. Future quality improvement efforts in the primary care setting should consider the neighborhoods of their patients in order to increase uptake of LCS following an order, while also including a qualitative component to allow for a better understanding of how patients experience their neighborhood context and how it may hinder or facilitate completion of an LCS order. Due to the retrospective nature of this study, we were unable to include a qualitative component which could have provided additional context for our findings. However, previous qualitative studies describe how patients express facing barriers to LCS order completion including the fear of being diagnosed with cancer, cost of LCS, and scheduling their LCS [56, 57].
Strengths and limitations
Our study examines several variables and their relationship with neighborhood deprivation to assess predictors of LCS completion rates. As previously stated, to our knowledge, this is the first study to assess the association of the ADI with LCS completion in a primary care context. This study moves beyond the individual-level and evaluates factors that are associated with neighborhood context. Another strength of this study includes utilizing data from a diverse population. The health system in this study cares for a nationally representative patient population of those eligible for LCS [15, 55, 58].
Our study is not without limitations. Due to our use of the EHR, we were limited to the variables collected in the EHR and potential inaccuracies in the data, including missing or misreported variables related to smoking history. For example, approximately 62% of the LCS orders either had a site listed not affiliated with the health system (i.e., community radiology location, Advanced Radiology) or the performing location was missing on the order form in the EHR. Due to this missing data, we used the 90 locations (seven locations were affiliated with the health system) from the ACR LCS locator tool in the analysis. Furthermore, due to the missing EHR data (Table 1), we were unable to assess the total sample for LCS eligibility. We were also unable to utilize the EHR to determine if patients were aware if an LCS order had been placed for them, although based on the typical workflow, patients are given a printout of the LCS order form during the clinical encounter. Additionally, we were unable to address the influence of comorbidities in our analysis due to a high percentage of incomplete data. Although published literature demonstrates that patient characteristics and neighborhood disadvantage have complex interrelationships that impact cancer screening behavior and outcomes [59–61], our study had insufficient sample size to examine interactions between these variables.
Our data is from solely one health system with patients primarily living in Maryland and D.C. which limits generalizability to other primary care practices in other regions of the United States. However, this integrated health system is the largest healthcare provider in Maryland and D.C., so we anticipate the results are likely representative of our catchment area. Finally, while the ADI is a commonly used measure of neighborhood SES, alternative measures of neighborhood SES or even multiple measures could better characterize the area-level factors that influence LCS. Future studies could examine interventions such as patient navigation to help patients schedule their LCS to the nearest site, transportation support, and mobile LCS programs to increase the LCS uptake among patients who live in socioeconomically disadvantaged neighborhoods.
Conclusions
Data from a large, socioeconomically diverse health system demonstrated how higher neighborhood disadvantage to nearest LCS site was associated with lower LCS completion among patients referred to screening. Primary care practices, with their focus on cancer screenings and key role as often being the first point of contact for LCS in the health care system, may be an effective setting to develop and implement quality improvement initiatives that consider neighborhood context to increase successful completion of LCS.
Supplementary Information
Acknowledgements
N/A.
Abbreviations
- U.S.
United States
- LCS
Lung cancer screening
- NELSON
Nederlands–Leuvens Longkanker Screenings Onderzoek
- SES
Socioeconomic status
- ADI
Area Deprivation Index
- EHR
Electronic Health Record
- D.C.
District of Columbia
- GEE
Generalized Estimating Equations
- ACR
American College of Radiology
- OR
Odds ratio
- CI
Confidence interval
- SD
Standard deviation
Authors’ contributions
All authors have contributed to the interpretation of the data, assisted with the draft of the manuscript, approved of the final submitted manuscript, and agreed to be personally accountable for the author’s own contributions and to ensure that questions related to the accuracy or integrity of any part of the work.
Funding
Supported by the National Cancer Institute, National Institutes of Health (R00CA256515) (R.M.W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Data availability
The dataset and analysis for the patient-level demographic, clinical, and address variables during the current study are not publicly available due to the inclusion of protected health information under HIPAA.The ADI dataset downloaded for use in the current study are available from the University of Wisconsin at https://www.neighborhoodatlas.medicine.wisc.edu/. Kind AJH, Buckingham WR. Making Neighborhood-Disadvantage Metrics Accessible — The Neighborhood Atlas. N Engl J Med. 2018;378(26):2456-2458. doi: 10.1056/NEJMp1802313.
Declarations
Ethics approval and consent to participate
The research adhered to the Declaration of Helsinki and the need for consent to participate was waived by the Georgetown-MedStar Institutional Review Board. This study was approved by the Georgetown-MedStar Institutional Review Board (STUDY00009269). This is a shared IRB between Georgetown University and MedStar Health.
Consent for publication
N/A.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.American cancer society. lung cancer statistics | How Common is Lung Cancer? https://www.cancer.org/cancer/types/lung-cancer/about/key-statistics.html. Accessed 16 Mar 2025.
- 2.De Koning HJ, Van Der Aalst CM, De Jong PA, et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med. 2020;382(6):503–13. 10.1056/NEJMoa1911793. [DOI] [PubMed] [Google Scholar]
- 3.National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409. 10.1056/NEJMoa1102873. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Poghosyan H, Sarkar S, Richman I, Pietrzak RH, Carter-Bawa L, Cooley ME. A Brief Report of Lung Cancer Screening Utilization Before, During, and in the Later Stages of the COVID-19 Pandemic in the United States. JTO Clin Res Rep. 2024;5(9):100705. 10.1016/j.jtocrr.2024.100705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Carter-Harris L, Gould MK. Multilevel Barriers to the Successful Implementation of Lung Cancer Screening: Why Does It Have to Be So Hard? Ann Am Thorac Soc. 2017;14(8):1261–5. 10.1513/AnnalsATS.201703-204PS. [DOI] [PubMed] [Google Scholar]
- 6.Sedani AE, Davis OC, Clifton SC, Campbell JE, Chou AF. Facilitators and Barriers to Implementation of Lung Cancer Screening: A Framework-Driven Systematic Review. JNCI J Natl Cancer Inst. 2022;114(11):1449–67. 10.1093/jnci/djac154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Haddad DN, Sandler KL, Henderson LM, Rivera MP, Aldrich MC. Disparities in lung cancer screening: A review. Ann Am Thorac Soc. 2020;17(4):399–405. 10.1513/AnnalsATS.201907-556CME. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Kim RY, Rendle KA, Mitra N, et al. Socioeconomic Status as a Mediator of Racial Disparity in Annual Lung Cancer Screening Adherence. Am J Respir Crit Care Med. 2023;207(6):777–80. 10.1164/rccm.202208-1590LE. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Neslund-Dudas C, Tang A, Alleman E, et al. Uptake of Lung Cancer Screening CT After a Provider Order for Screening in the PROSPR-Lung Consortium. J Gen Intern Med. 2024;39(2):186–94. 10.1007/s11606-023-08408-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Rubin G, Berendsen A, Crawford SM, et al. The expanding role of primary care in cancer control. Lancet Oncol. 2015;16(12):1231–72. 10.1016/S1470-2045(15)00205-3. [DOI] [PubMed] [Google Scholar]
- 11.Romaire MA. Use of Primary Care and Specialty Providers: Findings from the Medical Expenditure Panel Survey. J Gen Intern Med. 2020;35(7):2003–9. 10.1007/s11606-020-05773-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Klabunde CN, Ambs A, Keating NL, et al. The Role of Primary Care Physicians in Cancer Care. J Gen Intern Med. 2009;24(9):1029–36. 10.1007/s11606-009-1058-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Shay LA, Lafata JE. Where Is the Evidence? A Systematic Review of Shared Decision Making and Patient Outcomes. Med Decis Mak. 2015;35(1):114–31. 10.1177/0272989X14551638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kunitomo Y, Bade B, Gunderson CG, et al. Racial Differences in Adherence to Lung Cancer Screening Follow-up. Chest. 2022;161(1):266–75. 10.1016/j.chest.2021.07.2172. [DOI] [PubMed] [Google Scholar]
- 15.Gudina AT, Kamen CS, Hirko KA, et al. Lung Cancer Screening Uptake under the Revised United States Preventive Services Task Force Guideline: Assessing Disparities. Cancer Epidemiol Biomarkers Prev. 2025;34(1):35–41. 10.1158/1055-9965.EPI-24-0725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Lake M, Shusted CS, Juon HS, et al. Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up. BMC Cancer. 2020;20(1):561. 10.1186/s12885-020-06923-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Metwally EM, Rivera MP, Durham DD, et al. Lung Cancer Screening in Individuals With and Without Lung-Related Comorbidities. JAMA Netw Open. 2022;5(9):e2230146. 10.1001/jamanetworkopen.2022.30146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Zgodic A, Zahnd WE, Miller DP, Studts JL, Eberth JM. Predictors of Lung Cancer Screening Utilization in a Population-Based Survey. J Am Coll Radiol. 2020;17(12):1591–601. 10.1016/j.jacr.2020.06.015. [DOI] [PubMed] [Google Scholar]
- 19.Silvestri GA, Goldman L, Burleson J, et al. Characteristics of Persons Screened for Lung Cancer in the United States: A Cohort Study. Ann Intern Med. 2022;175(11):1501–5. 10.7326/M22-1325. [DOI] [PubMed] [Google Scholar]
- 20.Datta GD, Colditz GA, Kawachi I, Subramanian SV, Palmer JR, Rosenberg L. Individual-, neighborhood‐, and state‐level socioeconomic predictors of cervical carcinoma screening among U.S. black women: A multilevel analysis. Cancer. 2006;106(3):664–9. 10.1002/cncr.21660. [DOI] [PubMed] [Google Scholar]
- 21.Vutien P, Shah R, Ma K, Saleem N, Melson J. Utilization of Census Tract-Based Neighborhood Poverty Rates to Predict Non-adherence to Screening Colonoscopy. Dig Dis Sci. 2019;64(9):2505–13. 10.1007/s10620-019-05585-8. [DOI] [PubMed] [Google Scholar]
- 22.Lozano P, Randal FT, Peters A, et al. The impact of neighborhood disadvantage on colorectal cancer screening among African Americans in Chicago. Prev Med Rep. 2023;34:102235. 10.1016/j.pmedr.2023.102235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Kurani SS, McCoy RG, Lampman MA, et al. Association of Neighborhood Measures of Social Determinants of Health With Breast, Cervical, and Colorectal Cancer Screening Rates in the US Midwest. JAMA Netw Open. 2020;3(3):e200618. 10.1001/jamanetworkopen.2020.0618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Welch AC, Gorden JA, Mooney SJ, Wilshire CL, Zeliadt SB. Understanding Washington State’s Low Uptake of Lung Cancer Screening in Two Steps. Chest. 2024;166(3):622–31. 10.1016/j.chest.2024.04.021. [DOI] [PubMed] [Google Scholar]
- 25.Tailor TD, Choudhury KR, Tong BC, Christensen JD, Sosa JA, Rubin GD. Geographic Access to CT for Lung Cancer Screening: A Census Tract-Level Analysis of Cigarette Smoking in the United States and Driving Distance to a CT Facility. J Am Coll Radiol. 2019;16(1):15–23. 10.1016/j.jacr.2018.07.007. [DOI] [PubMed] [Google Scholar]
- 26.Sahar L, Douangchai Wills VL, Liu KK, Kazerooni EA, Dyer DS, Smith RA. Using Geospatial Analysis to Evaluate Access to Lung Cancer Screening in the United States. Chest. 2021;159(2):833–44. 10.1016/j.chest.2020.08.2081. [DOI] [PubMed] [Google Scholar]
- 27.Sahar L, Douangchai Wills VL, Liu KK (Antonio), editors editors. Geographic access to lung cancer screening among eligible adults living in rural and urban environments in the United States. Cancer. 2022;128(8):1584–1594. 10.1002/cncr.33996. [DOI] [PubMed]
- 28.Barta JA, Erkmen CP, Shusted CS, et al. The Philadelphia Lung Cancer Learning Community: a multi–health-system, citywide approach to lung cancer screening. JNCI Cancer Spectr. 2023;7(5):pkad071. 10.1093/jncics/pkad071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kind AJH, Buckingham WR. Making Neighborhood-Disadvantage Metrics Accessible — The Neighborhood Atlas. N Engl J Med. 2018;378(26):2456–8. 10.1056/NEJMp1802313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Bertini A, Cirulli GO, Stephens A, et al. Socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivation Index on PSA screening frequency. BJU Int. 2025;136(5):818–25. 10.1111/bju.16875. [DOI] [PubMed] [Google Scholar]
- 31.Biederman E, Baltic R, Katz ML, et al. Increasing breast, cervical, and colorectal cancer screening among rural women: Baseline characteristics of a randomized control trial. Contemp Clin Trials. 2022;123:106986. 10.1016/j.cct.2022.106986. [DOI] [PubMed] [Google Scholar]
- 32.Vachon EA, Katz ML, Rawl SM, et al. Comparative effectiveness of two interventions to increase colorectal cancer screening among females living in the rural Midwest. J Rural Health. 2024;40(4):610–22. 10.1111/jrh.12828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Cyriac J, Jenkins GD, Strelow BA, et al. A cross-sectional analysis of factors associated with cervical cancer screening in a large midwest primary care setting. BMC Womens Health. 2025;25(1):204. 10.1186/s12905-025-03741-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.MedStar Health. Hospital facts and figures. https://www.medstarhealth.org/about/facts-and-figures Accessed 2 Mar 2026.
- 35.Polubriaginof F, Salmasian H, Albert DA, Vawdrey DK. Challenges with Collecting Smoking Status in Electronic Health Records. AMIA Annu Symp Proc. 2018;2017:1392–1400. [PMC free article] [PubMed]
- 36.Kukhareva PV, Caverly TJ, Li H et al. Inaccuracies in electronic health records smoking data and a potential approach to address resulting underestimation in determining lung cancer screening eligibility. J Am Med Inform Assoc. Published online February 15, 2022:ocac020. 10.1093/jamia/ocac020. [DOI] [PMC free article] [PubMed]
- 37.Johnson AE, Zhu J, Garrard W, et al. Area Deprivation Index and Cardiac Readmissions: Evaluating Risk-Prediction in an Electronic Health Record. J Am Heart Assoc. 2021;10(13):e020466. 10.1161/JAHA.120.020466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.American College of Radiology. ACR Lung cancer screening locator tool. https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Screening-Resources/lung-cancer-resources/locator-tool. Accessed 2 Mar 2026.
- 39.American College of Radiology. ACR Designated lung cancer screening center. https://www.acr.org/Accreditation/Designations/Designated-Lung-Cancer-Screening-Center. Accessed 2 Mar 2026.
- 40.Esri, ArcGIS Pro. Published online 2024. https://pro.arcgis.com/en/pro-app/3.4/get-started/download-arcgis-pro.htm.
- 41.IBM. SPSS Statistics. https://www.ibm.com/products/spss-statistics.
- 42.Bandi P, Landy R, Star J, Kratzer TB, Smith RA, Jemal A. Lung Cancer Deaths Prevented and Life-Years Gained From Lung Cancer Screening. JAMA. 2025;334(24):2225. 10.1001/jama.2025.19798. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.US Preventive Services Task Force, Krist AH, Davidson KW, et al. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(10):962. 10.1001/jama.2021.1117. [DOI] [PubMed] [Google Scholar]
- 44.Boscoe FP, Liu B, Lee F. A comparison of two neighborhood-level socioeconomic indexes in the United States. Spat Spatio-Temporal Epidemiol. 2021;37:100412. 10.1016/j.sste.2021.100412. [DOI] [PubMed] [Google Scholar]
- 45.Yu M, Tatalovich Z, Gibson JT, Cronin KA. Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data. Cancer Causes Control. 2014;25(1):81–92. 10.1007/s10552-013-0310-1. [DOI] [PubMed] [Google Scholar]
- 46.Komrokji SER, Ayzenshtat L, Sangi-Haghpeykar H, et al. Geospatial Analysis of Accredited Lung Cancer Screening Facilities in Florida Reveals Suboptimal Alignment with High-Risk Populations. Cancer Res Commun. 2026;6(2):294–301. 10.1158/2767-9764.CRC-25-0535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Niranjan SJ, Opoku-Agyeman W, Carroll NW, et al. Distribution and Geographic Accessibility of Lung Cancer Screening Centers in the United States. Ann Am Thorac Soc. 2021;18(9):1577–80. 10.1513/AnnalsATS.202010-1313RL. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Williams PJ, Philip KE, Alghamdi SM, et al. Strategies to deliver smoking cessation interventions during targeted lung health screening - a systematic review and meta-analysis. Chron Respir Dis. 2023;20:14799731231183446. 10.1177/14799731231183446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Yang Y, Zhao W, Chan DNS, Zhou S, Choi KC, So WKW. Interventions targeted to improve lung cancer screening uptake among high-risk individuals: A systematic review and meta-analysis. Asia-Pac J Oncol Nurs. 2025;12:100746. 10.1016/j.apjon.2025.100746. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Satoh S, Shah M, Sungelo M, et al. Efficacy of Interventions Intended to Increase Lung Cancer Screening Rates: A Systematic Review and Meta-analysis. J Gen Intern Med. 2025;40(6):1288–96. 10.1007/s11606-024-09097-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Tao W, Tang X, Jiao X, et al. Effectiveness of interventions for increasing lung cancer screening uptake: A systematic review and meta-analysis of randomized clinical trials. Prev Med. 2026;203:108489. 10.1016/j.ypmed.2025.108489. [DOI] [PubMed] [Google Scholar]
- 52.Percac-Lima S, Ashburner JM, Rigotti NA, et al. Patient navigation for lung cancer screening among current smokers in community health centers a randomized controlled trial. Cancer Med. 2018;7(3):894–902. 10.1002/cam4.1297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Japuntich SJ, Krieger NH, Salvas AL, Carey MP. Racial Disparities in Lung Cancer Screening: An Exploratory Investigation. J Natl Med Assoc. 2018;110(5):424–7. 10.1016/j.jnma.2017.09.003. [DOI] [PubMed] [Google Scholar]
- 54.Carter-Harris L, Slaven JE, Monahan PO, Shedd-Steele R, Hanna N, Rawl SM. Understanding lung cancer screening behavior: Racial, gender, and geographic differences among Indiana long-term smokers. Prev Med Rep. 2018;10:49–54. 10.1016/j.pmedr.2018.01.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Williams RM, Li T, Luta G, et al. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data. Cancer. 2022;128(9):1812–9. 10.1002/cncr.34098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Williams RM, Whealan J, Sangraula A, et al. Providing Reminders and Education Prior to lung cancer screening: Feasibility and acceptability of a multilevel approach to address disparities in lung cancer screening. Transl Behav Med. 2025;15(1):ibaf008. 10.1093/tbm/ibaf008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Reihani AR, Ahari J, Manning EP, Cain HC, Bade BC, Zimmerman HG. Barriers and facilitators to lung cancer screening in the United States: A systematic review of the qualitative literature. J Health Soc Sci. Published online 2021:333–48. 10.19204/2021/brrr4.
- 58.Bandi P, Star J, Ashad-Bishop K, Kratzer T, Smith R, Jemal A. Lung Cancer Screening in the US, 2022. JAMA Intern Med. Published online June 2024;10. 10.1001/jamainternmed.2024.1655. [DOI] [PMC free article] [PubMed]
- 59.Doubeni CA, Jambaulikar GD, Fouayzi H et al. Neighborhood socioeconomic status and use of colonoscopy in an insured population – a retrospective cohort study. Gorlova OY, ed. PLoS ONE. 2012;7(5):e36392. 10.1371/journal.pone.0036392. [DOI] [PMC free article] [PubMed]
- 60.Cheng E, Soulos PR, Irwin ML, et al. Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers. JAMA Netw Open. 2021;4(12):e2139593. 10.1001/jamanetworkopen.2021.39593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Shariff-Marco S, Yang J, John EM, et al. Impact of Neighborhood and Individual Socioeconomic Status on Survival after Breast Cancer Varies by Race/Ethnicity: The Neighborhood and Breast Cancer Study. Cancer Epidemiol Biomarkers Prev. 2014;23(5):793–811. 10.1158/1055-9965.EPI-13-0924. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The dataset and analysis for the patient-level demographic, clinical, and address variables during the current study are not publicly available due to the inclusion of protected health information under HIPAA.The ADI dataset downloaded for use in the current study are available from the University of Wisconsin at https://www.neighborhoodatlas.medicine.wisc.edu/. Kind AJH, Buckingham WR. Making Neighborhood-Disadvantage Metrics Accessible — The Neighborhood Atlas. N Engl J Med. 2018;378(26):2456-2458. doi: 10.1056/NEJMp1802313.



